SEC Form SC 13G filed by Ultralife Corporation

2/14/23 12:23:15 PM ET

Industrial Machinery/Components

Miscellaneous

Get the next $ULBI alert in real time by email

SC 13G 1 ultralife13g12312022.txt ULTRALIFE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Ultralife Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 903899102 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person?s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be ?filed? for the purpose of Section 18 of the Securities Exchange Act of 1934 (?Act?) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP No. 903899102 1 Names of Reporting Persons Visionary Wealth Advisors (Tax ID: 46-5210986) 2 Check the appropriate box if a member of a Group (see instructions) (a) [ ] (b) [ ] 3 Sec Use Only 4 Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5 Sole Voting Power 8000 6 Shared Voting Power 0 7 Sole Dispositive Power 0 8 Shared Dispositive Power 1030135 9 Aggregate Amount Beneficially Owned by Each Reporting Person 1030135 10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions) [ ] 11 Percent of class represented by amount in row (9) 6.39% 12 Type of Reporting Person (See Instructions) IA Item 1. (a) Name of Issuer: Ultralife Corp. (b) Address of Issuer?s Principal Executive Offices: 200 Technology Parkway, Newark, NY 14513 Item 2. (a) Name of Person Filing: Visionary Wealth Advisors (b) Address of Principal Business Office or, if None, Residence: 1405 North Green Mount Rd., Suite 500, O?Fallon, IL 62208 (c) Citizenship: Delaware (d) Title and Class of Securities: Common Stock (e) CUSIP No.: 903899102 Item 3. If this statement is filed pursuant to ?? 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [_] Broker or dealer registered under Section 15 of the Act; (b) [_] Bank as defined in Section 3(a)(6) of the Act; (c) [_] Insurance company as defined in Section 3(a)(19) of the Act; (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940; (e) [X] An investment adviser in accordance with Rule 13d- 1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); (k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ Item 4. Ownership (a) Amount Beneficially Owned: 1030135 (b) Percent of Class: 6.39% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 8000 (ii) Shared power to vote or to direct the vote: 0 (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 1030135 Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of more than Five Percent on Behalf of Another Person. N/A Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. N/A Item 8. Identification and classification of members of the group. N/A Item 9. Notice of Dissolution of Group. N/A Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Sec. 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. VISIONARY WEALTH ADVISORS Dated: February 14, 2023 /s/ Ryan Barke Ryan Barke, Chief Compliance Officer Page 1 of 1

Get the next $ULBI alert in real time by email

SEC Form SC 13G filed by Ultralife Corporation

Chat with this insight

Recent Analyst Ratings for $ULBI

$ULBI Press Releases

Fastest customizable press release news feed in the world

Ultralife Corporation Reports Third Quarter Results

Ultralife Corporation Completes Acquisition of Electrochem Solutions, Inc.

Ultralife Corporation to Report Third Quarter Results on November 8, 2024

$ULBI Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Benchmark initiated coverage on Ultralife with a new price target

The Benchmark Company initiated coverage on Ultralife with a new price target

$ULBI Financials

Live finance-specific insights

Ultralife Corporation Reports Third Quarter Results

Ultralife Corporation to Report Third Quarter Results on November 8, 2024

Ultralife Corporation Reports Second Quarter Results

$ULBI Leadership Updates

Live Leadership Updates

Ultralife Corporation Names Michael E. Manna President & CEO

$ULBI Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Manna Michael Edward bought $10,868 worth of Common Stock; $.10 par value (1,500 units at $7.25), increasing direct ownership by 8% to 19,874 units (SEC Form 4)

Director Robert W. Shaw bought $19,775 worth of Common Stock; $.10 par value (2,500 units at $7.91), increasing direct ownership by 4% to 65,250 units (SEC Form 4)

SEC Form 4 filed by Director Whitmore Bradford T

$ULBI SEC Filings

SEC Form 10-Q filed by Ultralife Corporation

Ultralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Ultralife Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

$ULBI Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

President and CEO Manna Michael Edward bought $10,868 worth of Common Stock; $.10 par value (1,500 units at $7.25), increasing direct ownership by 8% to 19,874 units (SEC Form 4)

Director Robert W. Shaw bought $19,775 worth of Common Stock; $.10 par value (2,500 units at $7.91), increasing direct ownership by 4% to 65,250 units (SEC Form 4)

Goddard Janie bought $15,241 worth of Common Stock; $.10 par value (1,397 units at $10.91), increasing direct ownership by 47% to 4,381 units (SEC Form 4)

$ULBI Market Insights

Live Market Insights

$ULBI Large Ownership Changes

This live feed shows all institutional transactions in real time.

Ultralife Q2 Adj $0.22 Beats $0.14 Estimate, Sales $42.98M Beat $42.00M Estimate

Ultralife Corporation Becomes A Member Of Russell 2000 Index

Benchmark Maintains Buy on Ultralife, Raises Price Target to $14

Amendment: SEC Form SC 13D/A filed by Ultralife Corporation

SEC Form SC 13G filed by Ultralife Corporation

SEC Form SC 13G/A filed by Ultralife Corporation (Amendment)

Recent Analyst Ratings for
$ULBI

$ULBI
Press Releases

$ULBI
Analyst Ratings

$ULBI
Financials

$ULBI
Leadership Updates

$ULBI
Insider Trading

$ULBI
SEC Filings

$ULBI
Insider Purchases

$ULBI
Market Insights

$ULBI
Large Ownership Changes